SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-20-011200
Filing Date
2020-10-15
Accepted
2020-10-15 17:26:47
Documents
64
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form6-k.htm 6-K 25965
2 EXHIBIT 99.1 ex991.htm EX-99.1 719946
3 EXHIBIT 99.2 ex992.htm EX-99.2 1168311
4 EXHIBIT 99.3 ex993.htm EX-99.3 352934
5 EXHIBIT 99.4 ex994_ceo.htm EX-99.4 17547
6 EXHIBIT 99.5 ex995_cfo.htm EX-99.5 17542
7 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
  Complete submission text file 0001654954-20-011200.txt   5400495

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ipci-20200831.xml EX-101.INS 894361
9 XBRL TAXONOMY EXTENSION SCHEMA ipci-20200831.xsd EX-101.SCH 46589
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipci-20200831_cal.xml EX-101.CAL 44422
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipci-20200831_def.xml EX-101.DEF 86776
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipci-20200831_lab.xml EX-101.LAB 250154
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipci-20200831_pre.xml EX-101.PRE 179770
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-53805 | Film No.: 201242181
SIC: 2834 Pharmaceutical Preparations